Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

West Pharmaceutical Services Inc

Healthcare US WST

233.83USD
-14.23(5.74%)

Last update at 2026-03-10T20:00:00Z

Day Range

228.40243.14
LowHigh

52 Week Range

225.13415.48
LowHigh

Fundamentals

  • Previous Close 248.06
  • Market Cap26261.16M
  • Volume1411161
  • P/E Ratio47.83
  • Dividend Yield0.23%
  • EBITDA880.60M
  • Revenue TTM2926.50M
  • Revenue Per Share TTM39.34
  • Gross Profit TTM 1136.20M
  • Diluted EPS TTM7.42

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 679.90M 748.90M 401.30M 291.80M 240.70M
Minority interest - - - - 0.00000M
Net income 585.90M 661.80M 346.20M 241.70M 206.90M
Selling general administrative 343.70M 362.80M 302.00M 272.70M 262.90M
Selling and marketing expenses - - - - -
Gross profit 1136.20M 1175.80M 767.80M 605.70M 545.40M
Reconciled depreciation 120.60M 122.30M 109.10M 103.40M 104.40M
Ebit 734.00M 752.30M 406.90M 296.60M 142.60M
Ebitda 854.60M 878.40M 517.20M 399.90M 247.00M
Depreciation and amortization 120.60M 126.10M 110.30M 103.30M 104.40M
Non operating income net other -25.50000M 24.90M 20.00M 12.60M 16.40M
Operating income 734.00M 752.30M 406.90M 296.60M 240.30M
Other operating expenses 2152.90M 2079.30M 1740.00M 1545.80M 1475.20M
Interest expense 7.90M 7.20M 6.80M 4.70M 6.30M
Tax provision 114.70M 107.20M 72.50M 59.00M 41.40M
Interest income 2.80M 7.20M 6.80M 3.80M 2.10M
Net interest income -2.80000M -7.20000M -6.80000M -4.70000M -6.30000M
Extraordinary items 5.70M 1.40M - - 2.50M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense 114.70M 107.20M 72.50M 59.00M 41.40M
Total revenue 2886.90M 2831.60M 2146.90M 1839.90M 1717.40M
Total operating expenses 402.20M 423.50M 360.90M 311.60M 303.20M
Cost of revenue 1750.70M 1655.80M 1379.10M 1234.20M 1172.00M
Total other income expense net -54.10000M -3.40000M -5.60000M -4.80000M 4.80M
Discontinued operations - - - - 0.00000M
Net income from continuing ops 565.20M 641.70M 328.80M 232.80M 199.30M
Net income applicable to common shares 585.90M 661.80M 346.20M 232.80M 199.30M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 3616.80M 3313.80M 2793.80M 2341.40M 1592.40M
Intangible assets 18.40M 23.00M 30.50M 29.80M 20.40M
Earning assets - - - - -
Other current assets 103.00M 112.00M 51.60M 64.60M 54.30M
Total liab 931.90M 978.40M 939.30M 768.20M 196.10M
Total stockholder equity 2684.90M 2335.40M 1854.50M 1573.20M 1396.30M
Deferred long term liab 33.40M 33.80M 33.30M 15.50M 13.10M
Other current liab 228.10M 259.70M 226.90M 145.40M 127.70M
Common stock 18.80M 18.80M 18.80M 18.80M 18.80M
Capital stock 18.80M 18.80M 18.80M 18.80M 18.80M
Retained earnings 2987.80M 2456.70M 1846.70M 1549.40M 1353.40M
Other liab 113.20M 112.50M 117.00M 109.20M 102.90M
Good will 107.30M 109.90M 111.10M 107.80M 105.80M
Other assets 104.00M 104.40M 52.30M 43.00M -386.60000M
Cash 894.30M 762.60M 615.50M 439.10M 337.40M
Cash and equivalents 894.30M 762.60M 615.50M 439.10M 337.40M
Total current liabilities 519.00M 594.10M 503.40M 341.60M 283.70M
Current deferred revenue 57.30M 48.70M 51.00M 27.50M 25.50M
Net debt -576.40000M -437.30000M -289.80000M -109.80000M -141.30000M
Short term debt 18.20M 53.50M 12.40M 11.90M 0.10M
Short long term debt 2.20M 44.20M 2.30M 2.30M 0.10M
Short long term debt total 317.90M 325.30M 325.70M 329.30M 196.10M
Other stockholder equity -138.70000M 19.50M 99.60M 154.60M 178.30M
Property plant equipment 1158.30M 1057.50M 943.20M 839.30M 822.00M
Total current assets 1919.50M 1742.00M 1373.70M 1058.70M 894.40M
Long term investments 204.90M 207.70M 214.70M 192.70M 91.20M
Net tangible assets 2559.20M 2067.30M 1712.90M 1435.60M 1270.20M
Short term investments - - 214.00M - 0.00000M
Net receivables 507.40M 489.00M 385.30M 319.30M 288.20M
Long term debt 206.70M 208.80M 252.90M 255.00M 196.00M
Inventory 414.80M 378.40M 321.30M 235.70M 214.50M
Accounts payable 215.40M 232.20M 213.10M 156.80M 130.40M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income -183.00000M -159.60000M -110.60000M -149.60000M -154.20000M
Additional paid in capital - - - - 0.00000M
Common stock total equity 18.80M 18.80M 18.80M 18.80M 18.80M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity 2987.80M 2456.70M 1846.70M 1549.40M 1353.40M
Treasury stock -370.90000M -229.50000M -167.70000M -118.10000M -103.70000M
Accumulated amortization - - - - -
Non currrent assets other 38.40M 55.90M 36.30M 29.00M 20.50M
Deferred long term asset charges - - - 14.00M 24.70M
Non current assets total 1697.30M 1571.80M 1420.10M 1282.70M 1084.60M
Capital lease obligations 109.00M 72.30M 70.50M 72.00M -
Long term debt total 206.70M 208.80M 252.90M 255.00M 196.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -288.20000M -253.10000M -179.50000M -85.10000M -100.80000M
Change to liabilities -2.80000M 16.80M 36.60M 25.30M 0.40M
Total cashflows from investing activities -288.20000M -253.10000M -179.50000M -228.00000M -100.80000M
Net borrowings -45.50000M -2.20000M -2.30000M 60.90M -0.10000M
Total cash from financing activities -293.60000M -168.10000M -137.10000M -36.80000M -80.70000M
Change to operating activities 76.70M -0.60000M 73.40M 12.20M 22.10M
Net income 585.90M 661.80M 346.20M 241.70M 206.90M
Change in cash 131.70M 147.10M 176.40M 101.70M 101.50M
Begin period cash flow 762.60M 615.50M 439.10M 337.40M 235.90M
End period cash flow 894.30M 762.60M 615.50M 439.10M 337.40M
Total cash from operating activities 724.00M 584.00M 472.50M 367.20M 288.60M
Issuance of capital stock - - - - -
Depreciation 120.60M 122.30M 109.10M 103.40M 104.40M
Other cashflows from investing activities -3.60000M 0.30M -5.10000M -16.50000M 3.90M
Dividends paid -54.10000M -51.10000M -48.10000M -45.10000M 42.10M
Change to inventory -49.80000M -86.50000M -73.70000M -18.60000M -7.00000M
Change to account receivables -35.60000M -123.50000M -46.60000M -33.30000M -43.80000M
Sale purchase of stock -222.20000M -151.90000M -115.50000M -83.10000M -75.20000M
Other cashflows from financing activities 27.00M 37.10M 28.80M -1.20000M 36.70M
Change to netincome 29.70M -19.70000M 23.80M 37.30M 11.90M
Capital expenditures 284.60M 253.40M 174.40M 126.40M 104.70M
Change receivables -35.60000M -123.50000M -46.60000M -33.30000M -43.80000M
Cash flows other operating 76.00M 12.80M 77.10M 11.40M 15.80M
Exchange rate changes - -15.70000M 20.50M -0.70000M -5.60000M
Cash and cash equivalents changes 142.20M 147.10M 176.40M 101.70M 101.50M
Change in working capital -11.50000M -193.80000M -10.30000M -14.40000M -28.30000M
Stock based compensation 23.70M 37.50M 34.00M 24.40M 15.10M
Other non cash items 36.10M -0.90000M -0.70000M -3.20000M -10.40000M
Free cash flow 439.40M 330.60M 298.10M 240.80M 183.90M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
WST
West Pharmaceutical Services Inc		 -14.23 5.74% 233.83 47.83 40.00 8.84 9.02 8.63 31.56
ISRG
Intuitive Surgical Inc		 -7.71 1.56% 485.85 73.05 61.73 19.15 10.25 18.41 59.92
ESLOY
Essilor International SA		 -0.25 0.20% 122.50 35.39 24.81 3.63 2.20 4.00 16.25
ESLOF
EssilorLuxottica Société anonyme		 4.90 2.00% 249.71 35.71 25.13 3.62 2.23 4.00 16.25
BDX
Becton Dickinson and Company		 -1.58 0.95% 163.88 37.72 15.92 3.25 2.49 4.08 17.10

Reports Covered

Stock Research & News

View All

Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services Inc

530 Herman O. West Drive, Exton, PA, United States, 19341-0645

Key Executives

Name Title Year Born
Mr. Eric M. Green Chair, Pres & CEO 1970
Mr. Bernard J. Birkett Sr. VP and Chief Financial & Operations Officer 1969
Mr. Silji Abraham Sr. VP & Chief Technology Officer 1972
Ms. Kimberly Banks MacKay Sr. VP, Gen. Counsel & Company Sec. 1966
Mr. Chad R. Winters VP, Chief Accounting Officer & Corp. Controller 1979
Dr. Quintin J. Lai C.F.A., Ph.D. VP of Strategy & Investor Relations 1967
Michele Polinsky VP of Global Communications NA
Mr. Robert Segura VP of Corp. Devel. NA
Ms. Annette F. Favorite Chief HR Officer & Sr. VP 1965
Mr. Richard D. Luzzi Sr. VP of HR 1952

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.